PL1838341T3 - Kompozycja szczepionki obejmująca białko wiążące fibronektynę lub peptyd wiążący fibronektynę - Google Patents

Kompozycja szczepionki obejmująca białko wiążące fibronektynę lub peptyd wiążący fibronektynę

Info

Publication number
PL1838341T3
PL1838341T3 PL06701328T PL06701328T PL1838341T3 PL 1838341 T3 PL1838341 T3 PL 1838341T3 PL 06701328 T PL06701328 T PL 06701328T PL 06701328 T PL06701328 T PL 06701328T PL 1838341 T3 PL1838341 T3 PL 1838341T3
Authority
PL
Poland
Prior art keywords
fibronectin binding
vaccine composition
binding protein
binding peptide
peptide
Prior art date
Application number
PL06701328T
Other languages
English (en)
Inventor
Bror Morein
Karin Lövgren-Bengtsson
Katarina Ranlund
Birgitta Fromgren
Jill Ekström
Carlos Baschunan
Original Assignee
Isconova Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isconova Ab filed Critical Isconova Ab
Publication of PL1838341T3 publication Critical patent/PL1838341T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
PL06701328T 2005-01-20 2006-01-20 Kompozycja szczepionki obejmująca białko wiążące fibronektynę lub peptyd wiążący fibronektynę PL1838341T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59350405P 2005-01-20 2005-01-20
EP06701328.4A EP1838341B1 (en) 2005-01-20 2006-01-20 Vaccine composition comprising a fibronectin binding protein or a fibronectin binding peptide
PCT/SE2006/000082 WO2006078213A1 (en) 2005-01-20 2006-01-20 Vaccine composition comprisinga fibronectin binding protein or a fibronectin binding peptide

Publications (1)

Publication Number Publication Date
PL1838341T3 true PL1838341T3 (pl) 2014-04-30

Family

ID=36692518

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06701328T PL1838341T3 (pl) 2005-01-20 2006-01-20 Kompozycja szczepionki obejmująca białko wiążące fibronektynę lub peptyd wiążący fibronektynę

Country Status (9)

Country Link
US (2) US8007806B2 (pl)
EP (1) EP1838341B1 (pl)
CN (1) CN101107009B (pl)
BR (1) BRPI0606481A2 (pl)
CA (1) CA2592627C (pl)
DK (1) DK1838341T3 (pl)
ES (1) ES2433467T3 (pl)
PL (1) PL1838341T3 (pl)
WO (1) WO2006078213A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009539979A (ja) * 2006-06-12 2009-11-19 ナビ バイオファーマシューティカルズ ブドウ球菌感染症を治療および予防するための、α毒素の使用
JP2008013447A (ja) 2006-07-03 2008-01-24 Juntendo 毒素検出方法
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
KR20100072228A (ko) 2007-08-31 2010-06-30 유니버시티 오브 시카고 스타필로코커스 폐 질환 및 상태에 대한 면역화와 관련된 방법 및 조성물
US8758765B2 (en) 2008-07-29 2014-06-24 The University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
HRP20160274T1 (hr) 2009-04-03 2016-04-08 University Of Chicago Pripravci i metode vezane za varijante proteina a (spa)
AU2011274367B2 (en) 2010-07-02 2015-04-23 The University Of Chicago Compositions and methods related to protein A (SpA) variants
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
CN102993278B (zh) * 2012-09-29 2014-02-19 重庆原伦生物科技有限公司 耐甲氧西林金黄色葡萄球菌(MRSA)疫苗重组蛋白抗原FnbA1的纯化方法
EP4272750A3 (en) 2013-02-07 2024-01-24 Children's Medical Center, Corp. Protein antigens that provide protection against pneumococcal colonization and/or disease
CN106680483A (zh) * 2015-11-06 2017-05-17 中创云牧(内蒙古)科技咨询有限公司 金黄色葡萄球菌黏附素蛋白抗体的抗黏附能力的检测方法
BR112018067927A2 (pt) * 2016-03-09 2019-01-02 Technion Res & Development Found Ltd formulação, método de tratamento de plantas, método agrícola e kit
WO2019089755A1 (en) 2017-10-31 2019-05-09 Western Oncolytics Ltd. Platform oncolytic vector for systemic delivery
CN112912103B (zh) * 2018-05-21 2025-08-29 广州邦定生物技术有限公司 多价蛋白质复合物
CA3139981A1 (en) 2019-05-14 2020-11-19 The University Of Chicago Methods and compositions comprising staphylococcus protein a (spa) variants
US12528882B2 (en) 2019-09-13 2026-01-20 The University Of Chicago Methods and compositions for treating staphylococcal infections
JP2023552289A (ja) 2020-11-19 2023-12-15 カリヴィル イムノセラピューティクス， インコーポレイテッド 腫瘍微小環境リモデリングによる腫瘍溶解性免疫療法
EP4329786A4 (en) 2021-04-30 2024-12-11 KaliVir Immunotherapeutics, Inc. Oncolytic viruses for modified mhc expression
SE2200142A1 (en) * 2022-12-13 2024-06-14 Savacc Ab Chrisvacc

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
US5540933A (en) 1985-05-31 1996-07-30 La Jolla Cancer Research Foundation Isolation and use of fibronectin receptor
ES2039229T3 (es) 1986-01-14 1993-09-16 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Procedimiento para la preparacion de complejos inmunogenicos y composiciones farmaceuticas que contienen estos complejos.
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
CA1331443C (en) 1987-05-29 1994-08-16 Charlotte A. Kensil Saponin adjuvant
NZ230747A (en) 1988-09-30 1992-05-26 Bror Morein Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
JPH04503114A (ja) * 1989-09-08 1992-06-04 ウイスコンシン　アラムナイ　リサーチ　フオンデーション ブドウ球菌フィブロネクチン受容体抗体の検出試験
NL9000207A (pl) * 1990-01-29 1991-08-16 Duphar Int Res
US5270168A (en) * 1990-02-21 1993-12-14 Board Of Regents, The University Of Texas System Method for diagnosing non-healing ulcers
NL9002314A (nl) 1990-10-23 1992-05-18 Nederlanden Staat Immunogene complexen, in het bijzonder iscoms.
US5618916A (en) 1993-01-06 1997-04-08 The Jewish Hospital Of St. Louis Purified protein which functions as a mycobacterial receptor for fibronectin
WO1995024470A1 (en) 1994-03-09 1995-09-14 Pacific Biotech International, Inc. Activating virus
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
US20010053365A1 (en) * 1995-04-25 2001-12-20 Smithkline Beecham Biologicals S.A. Vaccines
US5753235A (en) 1996-02-15 1998-05-19 Heska Corporation Recombinant canine herpesviruses
SE9600647D0 (sv) 1996-02-21 1996-02-21 Bror Morein Ny användning
US6288214B1 (en) * 1996-05-16 2001-09-11 Texas A&M University Systems Collagen binding protein compositions and methods of use
ES2157522T3 (es) 1996-10-09 2001-08-16 Akzo Nobel Nv Cepas de vacunas europeas del virus del sindrome respiratorio reproductor porcino (prrsv).
US6231859B1 (en) 1996-12-02 2001-05-15 Aquila Biopharmaceuticals, Inc. Saponin adjuvant compositions
US6685943B1 (en) * 1997-01-21 2004-02-03 The Texas A&M University System Fibronectin binding protein compositions and methods of use
AUPO517897A0 (en) 1997-02-19 1997-04-11 Csl Limited Chelating immunostimulating complexes
US6558670B1 (en) 1999-04-19 2003-05-06 Smithkline Beechman Biologicals S.A. Vaccine adjuvants
SE0202110D0 (sv) 2002-07-05 2002-07-05 Isconova Ab Iscom preparation and use thereof
JP2006503072A (ja) 2002-10-02 2006-01-26 ノルディック ワクチン テクノロジー アクティーゼルスカブ ワクチン接種用組成物
SE0300795D0 (sv) 2003-03-24 2003-03-24 Isconova Ab Composition comprising iscom particles and live micro-organisms
SE0301998D0 (sv) 2003-07-07 2003-07-07 Isconova Ab Quil A fraction with low toxicity and use thereof

Also Published As

Publication number Publication date
US8187585B2 (en) 2012-05-29
EP1838341B1 (en) 2013-08-14
US20110303563A1 (en) 2011-12-15
WO2006078213A1 (en) 2006-07-27
US8007806B2 (en) 2011-08-30
US20090208562A1 (en) 2009-08-20
BRPI0606481A2 (pt) 2009-06-30
CN101107009B (zh) 2014-08-06
DK1838341T3 (da) 2013-11-04
ES2433467T3 (es) 2013-12-11
EP1838341A1 (en) 2007-10-03
CN101107009A (zh) 2008-01-16
CA2592627C (en) 2014-02-25
CA2592627A1 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
IL191718A0 (en) Binding proteins specific for insulin-like growth factors and uses thereof
IL190180A0 (en) Compositions containing calcium binding peptides
IL188345A (en) A binding protein specific to cd37
EP1889908A4 (en) PROTEIN FUSED WITH ANTI-CD14 ANTIBODY
IL192487A0 (en) Non-natural amino acid polypeptides having modulated immunogenicity
ZA200801389B (en) II-6 Binding proteins
GB0508863D0 (en) Peptide
DK1838341T3 (da) Vaccinesammensætning omfattende et fibronectin bindende protein eller et fibronectinbindende peptid
ZA200802571B (en) GDNF derived peptides
EP1817046A4 (en) NEW ANTIMICROBIAL PEPTIDES
GB0514482D0 (en) Protein
ZA200804925B (en) Binding proteins specific for insulin-like growth factors and uses thereof
GB0526019D0 (en) Peptides
GB0516527D0 (en) Peptides
IL190926A0 (en) A pharmaceutical composition containing a tissue protein
ZA200610190B (en) Heparin binding peptide
GB0511861D0 (en) Proteins
GB0522113D0 (en) vWFA-domain containing proteins
GB0523953D0 (en) Peptides
GB0512969D0 (en) Peptides
GB0516303D0 (en) Peptide
ZA200709294B (en) Peptide
GB0423128D0 (en) Peptides
GB0425033D0 (en) Peptides
GB0513505D0 (en) Proteins